Product image of Levonorgestrel/Ethinylestradiol Eg (Ethinylestradiol, Levonorgestrel) supplied by GNH India

Levonorgestrel/Ethinylestradiol Eg

Active Ingredient:
Ethinylestradiol, Levonorgestrel
Origin:
EU

Levonorgestrel/Ethinylestradiol Eg (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol and Levonorgestrel, the active ingredients in Levonorgestrel/Ethinylestradiol Eg, are a combined oral contraceptive presented as a tablet for oral use. It is prescribed to prevent pregnancy and to help regulate the menstrual cycle in women of reproductive age.

GNH India supplies Levonorgestrel/Ethinylestradiol Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eg Labo Laboratoires Eurogenerics

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levonorgestrel/Ethinylestradiol is a combined hormonal contraceptive used to manage reproductive health.

  • Prevention of pregnancy: provides reliable contraceptive protection when taken as directed.
  • Menstrual cycle regulation: helps achieve more predictable bleeding patterns.
  • Management of dysmenorrhea: reduces menstrual pain and excessive flow.

How It Works

  • Levonorgestrel/Ethinylestradiol works by delivering synthetic estrogen (ethinylestradiol) and progestin (levonorgestrel) that suppress the hypothalamic‑pituitary‑ovarian axis, preventing the mid‑cycle surge of luteinizing hormone and thereby inhibiting ovulation. The progestin also thickens cervical mucus and alters the endometrial lining, creating an environment unfavorable for fertilization and implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Breast tenderness: temporary swelling or soreness.
  • Headache: occasional tension‑type headache.
  • Spotting or breakthrough bleeding: irregular light bleeding.
  • Mood changes: mild emotional fluctuations.
  • Weight change: slight fluid‑related weight variation.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clot formation in deep veins.
  • Stroke or myocardial infarction: rare cerebrovascular or cardiac events.
  • Liver tumor: benign hepatic adenoma.
  • Severe allergic reaction: anaphylaxis or angioedema.
  • Hypertension: sudden increase in blood pressure.

Precautions & Warnings

Before initiating therapy, consider the following precautions.

  • Medical history review: assess for personal or family history of thromboembolic disorders.
  • Smoking status: avoid use in women over 35 who smoke.
  • Medication review: evaluate concurrent drugs that may affect hormone metabolism.
  • Pregnancy testing: confirm non‑pregnant status prior to starting.
  • Regular monitoring: check blood pressure and menstrual patterns during treatment.
  • Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levonorgestrel/Ethinylestradiol may interact with several medicines.

Major Interactions (Avoid)

  • Strong enzyme inducers (e.g., rifampin, carbamazepine): may reduce contraceptive efficacy.
  • Anticoagulants (e.g., warfarin): hormonal changes can alter clotting risk.
  • HIV protease inhibitors: may affect hormone levels and effectiveness.

Moderate Interactions (Monitor Closely)

  • SSRIs (e.g., fluoxetine): may increase risk of mood‑related side effects.
  • Antifungals (e.g., ketoconazole): can raise hormone concentrations.
  • St. John’s wort: may decrease contraceptive reliability.

Frequently Asked Questions

Levonorgestrel/Ethinylestradiol Eg is a combined hormonal contraceptive used primarily to prevent pregnancy and to help regulate menstrual cycles in women of reproductive age. It may also be prescribed to manage menstrual-related symptoms such as dysmenorrhea.

The product contains synthetic estrogen (ethinylestradiol) and progestin (levonorgestrel). Together they suppress the hormonal surge that triggers ovulation, thicken cervical mucus to block sperm entry, and alter the uterine lining to reduce the likelihood of implantation.

The specific dosing regimen, including tablet strength and schedule, is determined by the prescribing healthcare professional based on individual patient factors and local prescribing guidelines. Patients should follow the prescriber’s instructions exactly.

Levonorgestrel/Ethinylestradiol is contraindicated during pregnancy because it is intended to prevent conception. If pregnancy occurs, the medication should be stopped and a healthcare provider consulted. Limited data exist for breastfeeding; clinicians usually advise caution and may recommend alternative contraception.

Enquiries can be submitted on the product page at gnhindia.com by specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Compared with progestin‑only pills, the combined formulation offers more consistent cycle control and may reduce menstrual symptoms. However, combined pills carry a higher risk of thromboembolic events, especially in smokers over 35, whereas progestin‑only options have a lower clotting risk but may cause irregular bleeding.

Store the tablets at ambient temperature, preferably below 25 °C, in the original blister pack. Protect them from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf life.

The medication is taken orally, usually once daily at the same time each day. Patients should swallow the tablet whole with water and start a new pack after completing the previous one, following the prescriber’s cycle schedule.

Serious risks include venous thromboembolism, stroke, myocardial infarction, severe allergic reactions, and hepatic adenomas. Women with a history of clotting disorders, smoking over age 35, or uncontrolled hypertension should be closely evaluated before use.

Women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or who are smokers over 35 years old should avoid this medication. A thorough medical assessment is essential before initiation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT